Essex Bio-Technology

Essex Bio Group is an investor and manufacturer of biopharmaceutical products.

Business Model:

Revenue: $115.1M

Employees: 1,001-5,000

Rankings

Detailed Essex Bio-Technology Information

Geographic Data

Essex Bio-Technology headquarters map

Address: 168-200 Connaught Road Central

City: Hong Kong

State: other

Zip:

Country: HK

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Essex Bio-Technology Limited (“EssexBio Group” and the “Company”) was incorporated in the Cayman Islands on 31st July, 2000 and has been listed on the Stock Exchange of Hong Kong since 27th June, 2001. Essex specializes in biopharmaceutical drug development based on recombinant DNA technology. It is principally engaged in the manufacture and sale of biopharmaceutical products for the treatment and healing of surface wounds and eye wounds. The Group also engaged in the research and development of bFGF products for new indications, as well as other ophthalmic pharmaceutical projects. A series of genetically engineered bio-pharmaceutical drugs have been successfully developed and three of them were classified as State-level Category I new drugs. The main brands of the Company&s;s products are Beifuji, Beifushu and Beifuxin.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
7/2018 Shang Gong Series A 0
5/2018 X-ZELL Seed Round 4M
3/2018 MeiraGTx Series B 5M
7/2018 Shang Gong Series A 0
5/2018 X-ZELL Seed Round 0
3/2018 MeiraGTx Series B 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research